Search Results

You are looking at 11 - 20 of 2,671 items for :

  • Refine by Access: All x
Clear All
Full access

Julie Hallet, Bourke Tillman, Jesse Zuckerman, Matthew P. Guttman, Tyler Chesney, Alyson L. Mahar, Wing C. Chan, Natalie Coburn, Barbara Haas, and members of the Recovery after Surgical Therapy for Older adults Research–Cancer (RESTORE-Cancer) Group

essential for older adults. However, there are few data on functional outcomes after cancer surgery, with most studies limited to 6- to 12-month time horizons. 12 – 19 Lack of data regarding these outcomes impacts the accuracy of prognostication and can

Full access

Martin J. Edelman, Daniel P. Raymond, Dwight H. Owen, Michelle B. Leavy, Kari Chansky, Sriram Yennu, Felix G. Fernandez, Carolyn J. Presley, Tithi Biswas, Gwendolyn P. Quinn, Matthew B. Schabath, Seth Sheffler-Collins, Laura Chu, and Richard E. Gliklich

immunotherapy with chemotherapy, and which patients are unlikely to receive clinical benefit from immunotherapy. To address these and other research questions critical to improving patient outcomes, innovative research strategies and high-quality sources of data

Full access

Eric J. Bow

economic outcomes of hematopoietic stem-cell transplantation . J Clin Oncol 2001 ; 19 : 2201 – 2205 . 12 Sonis ST Elting LS Keefe D . Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and

Full access

George Rodrigues, Himu Lukka, Padraig Warde, Michael Brundage, Luis Souhami, Juanita Crook, Fabio Cury, Charles Catton, Gary Mok, Andre-Guy Martin, Eric Vigneault, Jim Morris, Andrew Warner, Sandra Gonzalez Maldonado, Tom Pickles, and the Genitourinary Radiation Oncologists of Canada (GUROC)

pretreatment risk stratification systems have been published to support decision-making, interphysician communication, clinical trial stratification/design, and outcome reporting in nonmetastatic prostate cancer. Five unique commonly used systems (not

Full access

Tarah J. Ballinger, Helga S. Marques, Gloria Xue, Richard Hoffman, Constantine Gatsonis, Fengmin Zhao, Kathy D. Miller, Joseph Sparano, and Roisin M. Connolly

Background Observational data investigating the relationship between body habitus and outcomes in breast cancer have been largely centered in the curative setting and focused on weight-based metrics, with variable and inconsistent results

Full access

Christopher Nevala-Plagemann, Siddharth Iyengar, Andrew D. Trunk, Lisa Pappas, Benjamin Haaland, and Ignacio Garrido-Laguna

over the past several decades. This decrease is likely attributable to improved detection of early-stage disease through increased use of appropriate cancer screening and improvements in cytotoxic and targeted therapy. Unfortunately, outcomes for

Full access

Thomas A. D'Amico

patients. 12 , 13 Despite these outcomes, the advantages of thoracoscopic lobectomy seem to be underused. From 1999 to 2006, only 20% of all lobectomies for NSCLC were performed thoracoscopically by the board-certified thoracic surgeons participating in

Full access

P. Connor Johnson, Caron Jacobson, Alisha Yi, Anna Saucier, Tejaswini M. Dhawale, Ashley Nelson, Mitchell W. Lavoie, Mathew J. Reynolds, Carlisle E.W. Topping, Matthew J. Frigault, and Areej El-Jawahri

, 5 , 11 However, data describing healthcare utilization and end-of-life (EoL) outcomes in this population are lacking. In the present study, we sought to describe the healthcare utilization and EoL outcomes among patients treated with CAR T

Full access

Michelle Guan, Gillian Gresham, Arvind Shinde, Isaac Lapite, Jun Gong, Veronica R. Placencio-Hickok, Christopher B. Forrest, and Andrew E. Hendifar

goals to be adequately considered when treatment decisions are made. 5 Historically, priorities in oncology emphasized clinical outcomes and the evaluation of tumor response based on physician interpretation of parameters such as laboratory values, tumor

Full access

Kavea Panneerselvam, Rajan N. Amin, Dongguang Wei, Dongfeng Tan, Phillip J. Lum, Hao Chi Zhang, David M. Richards, Mehmet Altan, Petros Grivas, John A. Thompson, Anusha S. Thomas, and Yinghong Wang

initiation of treatment with anti–PD-1 agents. Other than these few cases, there has been little published literature describing the endoscopic and histologic features of ICI-related esophagitis, treatment response, or clinical outcomes. There is a gap in